Wearable sensors mimic skin to help with wound healing process

02 Apr 2019

1

Researchers at Binghamton University, State University of New York, have developed skin-inspired electronics to conform to the skin, allowing for long-term, high-performance, real-time wound monitoring in users.

"We eventually hope that these sensors and engineering accomplishments can help advance healthcare applications and provide a better quantitative understanding in disease progression, wound care, general health, fitness monitoring and more," said Matthew Brown, a PhD student at Binghamton University.
Biosensors are analytical devices that combine a biological component with a physiochemical detector to observe and analyze a chemical substance and its reaction in the body. Conventional biosensor technology, while a great advancement in the medical field, still has limitations to overcome and improvements to be made to enhance their functionality. Researchers at Binghamton University's Intimately Bio-Integrated Biosensors lab have developed a skin-inspired, open-mesh electromechanical sensor that is capable of monitoring lactate and oxygen on the skin.
"We are focused on developing next-generation platforms that can integrate with biological tissue (e.g. skin, neural and cardiac tissue)," says Brown. Under the guidance of Assistant Professor of Biomedical Engineering Ahyeon Koh, Brown, master's students Brandon Ashely and Youjoong Park, and undergraduate student Sally Kuan designed a sensor that is structured similarly to that of the skin's micro architecture. This wearable sensor is equipped with gold sensor cables capable of exhibiting similar mechanics to that of skin elasticity.
The researchers hope to create a new mode of sensor that will meld seamlessly with the wearer's body to maximize body analysis to help understand chemical and physiological information.
"This topic was interesting to us because we were very interested in real-time, on-site evaluation of wound healing progress in a near future," says Brown. "Both lactate and oxygen are critical biomarkers to access wound-healing progression."
They hope that future research will utilize this skin-inspired sensor design to incorporate more biomarkers and create even more multifunctional sensors to help with wound healing. They hope to see these sensors being developed incorporated into internal organs to gain an increased understanding about the diseases that affect these organs and the human body.
"The bio-mimicry structured sensor platform allows free mass transfer between biological tissue and bio-interfaced electronics," says Koh. "Therefore, this intimately bio-integrated sensing system is capable of determining critical biochemical events while being invisible to the biological system or not evoking an inflammatory response."

Latest articles

Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

AI startup Reflection signs over $1 billion computing deal with Nebius

AI startup Reflection signs over $1 billion computing deal with Nebius

Tata Power explores $450 million overseas loan for business operations

Tata Power explores $450 million overseas loan for business operations

TCS wins technology contract for New York JFK Airport’s $19 billion terminal

TCS wins technology contract for New York JFK Airport’s $19 billion terminal

South Korean firms unveil $195 billion investment in AI and advanced industries

South Korean firms unveil $195 billion investment in AI and advanced industries

HCLTech wins $1.14 billion AI transformation deal with European client

HCLTech wins $1.14 billion AI transformation deal with European client

Microsoft launches Frontier to help enterprises accelerate AI adoption

Microsoft launches Frontier to help enterprises accelerate AI adoption

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs
View details about the software product Informachine File Manager
View details about the software product Informachine News Trackers